Clinical trials
Terminated Phase 1 Small Cell Lung Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2007 | 2 |
| 2009 | 3 |
| 2010 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2019 | 5 |
| 2020 | 7 |
| 2021 | 2 |
| 2023 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 40 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Maastricht Radiation Oncology | 2 |
| National Cancer Institute (NCI) | 2 |
| Pfizer | 2 |
| AbbVie | 1 |
| Ahmad Tarhini | 1 |
| Aileron Therapeutics, Inc. | 1 |
| Ascentage Pharma Group Inc. | 1 |
| AstraZeneca | 1 |
| Augusta University | 1 |
| Bayer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Cell Lung Carcinoma | 40 |
| Carcinoma, Non-Small-Cell Lung | 16 |
| Carcinoma, Renal Cell | 8 |
| Lung Neoplasms | 8 |
| Melanoma | 8 |
| Carcinoma, Merkel Cell | 7 |
| Ovarian Neoplasms | 7 |
| Stomach Neoplasms | 7 |
| Carcinoma, Hepatocellular | 6 |
| Carcinoma, Transitional Cell | 6 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.